Myocardial (123)I-MIBG scintigraphy for differentiation of Lewy bodies disease from FTD.
about
Cerebrospinal fluid biomarkers for dementia with lewy bodies.Diagnostic performance of myocardial innervation imaging using MIBG scintigraphy in differential diagnosis between dementia with lewy bodies and other dementias: a systematic review and a meta-analysis.Biomarkers in dementia with Lewy bodies: a review.(123) I-2β-carbomethoxy-3β-(4-iodophenyl)-N-(3-fluoropropyl) nortropane single photon emission computed tomography and (123) I-metaiodobenzylguanidine myocardial scintigraphy in differentiating dementia with lewy bodies from other dementias: A compa
P2860
Myocardial (123)I-MIBG scintigraphy for differentiation of Lewy bodies disease from FTD.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
Myocardial (123)I-MIBG scintigraphy for differentiation of Lewy bodies disease from FTD.
@en
type
label
Myocardial (123)I-MIBG scintigraphy for differentiation of Lewy bodies disease from FTD.
@en
prefLabel
Myocardial (123)I-MIBG scintigraphy for differentiation of Lewy bodies disease from FTD.
@en
P2093
P50
P1476
Myocardial (123)I-MIBG scintigraphy for differentiation of Lewy bodies disease from FTD
@en
P2093
Antonio Bagnato
Carmelina Chiriaco
Gennarina Arabia
Pierfrancesco Pugliese
Sandra Paglionico
Stefania Cipullo
P304
P356
10.1016/J.NEUROBIOLAGING.2008.11.009
P50
P577
2009-01-09T00:00:00Z